Life Sciences & Health

Life Sciences & Healthcare

Our dynamic and progressive Life Sciences team is nimble, creative and innovative in their approach to pushing the boundaries of science and law and bringing you closer to your aspirations and goals.

Jump straight to:

Patent Litigation Firm of the Year: Pharmaceuticals

LMG Life Sciences Awards EMEA 2023

2 x Impact Cases of the Year

LMG Life Sciences Awards EMEA 2023

Tier 1 Life Sciences and Healthcare

Legal 500 2024

Our team offers clients a full-service approach, with transactional, tax, competition, intellectual property, medicines regulatory and compliance professionals working seamlessly together to support Life Sciences companies who push the boundaries of science and law.

 

Please select

Out-Law / Your daily need to know in Life Sciences & Healthcare

Our latest work

Our advisers act on domestic and international projects of all shapes and sizes, working with many of the leading names across this diverse sector. Browse our experience below, or use the filters to look-up recent work in particular geographies and legal disciplines.

    Our expertise, at your disposal

    With over 490 partners and 3000 people around the world, we are well-placed to support you across a full range of legal and advisory services.

    Latest press releases

    Show me all press releases

    Pinsent Masons advises on The Real Greek pre-pack sale

    Multinational law firm Pinsent Masons has advised on the sale of The Real Greek restaurant chain via a pre-packaged administration, acting for the company and subsequently the administrators in delivering the restructuring.

    Pinsent Masons advises on Franco Manca CVA

    Multinational law firm Pinsent Masons has advised the operating company of the UK pizza restaurant chain, Franco Manca, on its company voluntary arrangement (CVA). Paul Berkovi and Rob Croxen of financial advisory firm, Alvarez & Marsal, have been appointed as supervisors of the CVA.

    Global study from Pinsent Masons finds CCS remains dominant, but low-carbon investors looking to diversify

    New research from multinational law firm Pinsent Masons shows carbon capture and storage (CCS) remains a global priority for low-carbon players, with 90% of respondents having already invested in or developed a CCS project and 78% planning to do so again in the year ahead.  

    We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.